CJC-1295 without DAC, also known as MOD GRF 1-29, is a synthetic analogue of growth hormone releasing hormone (GHRH) comprising the first 29 amino acids of the native sequence, modified at four key positions to enhance metabolic stability and receptor binding affinity. Unlike its DAC-containing counterpart, this variant lacks the Drug Affinity Complex, resulting in a shorter half-life of approximately 30 minutes and a more physiologically representative, pulsatile pattern of growth hormone release — a characteristic that makes it particularly valuable in research settings.
In preclinical studies, MOD GRF 1-29 has been investigated for its capacity to stimulate the anterior pituitary to secrete endogenous growth hormone, subsequently elevating insulin-like growth factor 1 (IGF-1) levels. Researchers have explored its potential applications across areas including metabolic function, body composition modulation, bone density, and recovery processes.
This product is supplied as a lyophilised powder with a purity exceeding 98%, as verified by HPLC analysis. Molecular formula: C₁₅₂H₂₅₂N₄₄O₄₂. Molecular weight: 3367.9 g/mol. CAS number: 863288-34-0. Each vial contains 2mg of peptide. Recommended storage is at -20°C, protected from light and moisture, to maintain stability and potency.
Molecular Formula
C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight
3367.9 g/mol
Purity
>98%
CAS Number
863288-34-0
Form
Lyophilised Powder
Research Applications
Growth hormone secretion, IGF-1 modulation, metabolic function, body composition research, bone density studies, pituitary function
For research purposes only. Not for human use.


Reviews
There are no reviews yet.